Chemical activators of Vmn2r90 can initiate a cascade of cellular events leading to its activation. Adenosine Triphosphate (ATP), for instance, can bind to P2X and P2Y receptors, which are a type of G protein-coupled receptor (GPCR). The activation of these receptors by ATP can trigger downstream intracellular signaling pathways that ultimately lead to the activation of Vmn2r90. Similarly, acetylcholine can activate both muscarinic and nicotinic receptors, and histamine can activate histamine receptors, both of which are classes of GPCRs. The engagement of these receptors by their respective ligands initiates signaling processes that converge on the activation of Vmn2r90. Furthermore, serotonin, dopamine, noradrenaline, and epinephrine, all of which are neurotransmitters, can bind to their specific GPCR targets, thereby initiating a sequence of reactions that activate Vmn2r90 through various intracellular signaling mechanisms.
Additionally, isoproterenol, a synthetic catecholamine, can activate beta-adrenergic receptors, which leads to the accumulation of cyclic AMP (cAMP) and activation of protein kinase A (PKA). This signaling cascade can then activate Vmn2r90. Forskolin, a diterpene, directly activates adenylate cyclase, which catalyzes the conversion of ATP to cAMP, leading to PKA activation and subsequent Vmn2r90 activation. Sodium Nitroprusside, a nitric oxide donor, can release nitric oxide that activates guanylate cyclase, increasing cyclic GMP (cGMP) levels, which can then activate Vmn2r90 through cGMP-dependent pathways. Glutamate, an excitatory neurotransmitter, can activate various glutamate receptors, such as NMDA, AMPA, and kainate receptors, leading to calcium influx and the activation of intracellular pathways that can activate Vmn2r90. Lastly, anandamide, an endocannabinoid, can activate cannabinoid receptors and initiate downstream signaling pathways culminating in the activation of Vmn2r90, demonstrating the diverse mechanisms through which Vmn2r90 can be activated by chemical ligands.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine 5′-Triphosphate, disodium salt | 987-65-5 | sc-202040 sc-202040A | 1 g 5 g | $39.00 $75.00 | 9 | |
ATP, by binding to and activating P2X and P2Y receptors, which are G protein-coupled receptors (GPCRs), can lead to a cascade of intracellular signaling events that result in the activation of Vmn2r90. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine activates histamine receptors, which are GPCRs, triggering intracellular pathways that lead to the activation of Vmn2r90. | ||||||
Serotonin hydrochloride | 153-98-0 | sc-201146 sc-201146A | 100 mg 1 g | $118.00 $187.00 | 15 | |
Serotonin binds to serotonin receptors, which are GPCRs, and through secondary messenger systems, can activate Vmn2r90. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine interacts with dopamine receptors, which are GPCRs, and this engagement activates intracellular signaling pathways that activate Vmn2r90. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Noradrenaline, through its action on adrenergic receptors, activates signaling cascades that lead to the activation of Vmn2r90. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors, which are GPCRs, and this binding initiates signaling pathways that activate Vmn2r90. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol activates beta-adrenergic receptors leading to cAMP accumulation and PKA activation, which subsequently activates Vmn2r90. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Sodium Nitroprusside releases nitric oxide, which activates guanylate cyclase, increasing cGMP levels that can activate Vmn2r90 through cGMP-dependent pathways. | ||||||
L-Glutamic Acid | 56-86-0 | sc-394004 sc-394004A | 10 g 100 g | $297.00 $577.00 | ||
Glutamate activates glutamate receptors (such as NMDA, AMPA, and kainate receptors), leading to calcium influx and activation of intracellular pathways that activate Vmn2r90. | ||||||